Member Info for AB124

RW

What splinters?

I never suggested that LD was selling to take up options. That was EE's pet idea.

All I said was that if it was the case ten it was an inept move and explained why it was inept (particularly for her credibility as well as those who advised her to do it.

Since it wasn't LD hasn't done anything stupid and therefore her credibility remains intact.

Don't see a problem with explaining that had the options been funded in a way that was suggested there was a disconnect between reality and Scancell's supposed lack of naus.

So the question now remains as to who was the big seller and why.

I'll stick with the idea of Vulpes who have been very prompt with their reporting of dealings in the past.

If no RNS then who knows?

Thanks for giving me the chance to put you right RW and also to point out how others might try and "Explain" large sales of SCLP shares in ways that defy commercial commonsense in the context of Scancell and their current situation.

AIMO

I don't agree with the contents of the link.

BUT

It's EXACTLY the sort of write up you get when your SP dumps such as was the case yesterday.

Now tell me that it's OK for LD to do what she wants. (I still hope it wasn't the CEO selling yesterday).

Or maybe I'm wrong.

AIMO

I'm still not convinced it was LD who upset the applecart. I hope it wasn't because there's more ways to skin a cat than dump the SP.

If it was however, then I think it calls into question her judgement. To simply sell Shares on that scale on a day when the SP was still being affected by a not altogether brilliantly crafted RNS would only have resulted in one thing and that duly came to pass with Scancell hitting the leaderboards for all the wrong reasons.

Maybe people feel the CEO can do what she likes. OK, it's free country, but destroying the SP in a blatantly inept funding for option take up is not the best way to demonstrate financial expertise and nous, or much of a care for the shareholder's confidence.

That's why I'd be amazed (and disappointed) if it was an LD options action.

It wasn't clever.

AIMO

Rob,

No worries.

Maybe they went short into the drop...

That would be a turnup... :-)

AIMO

Rob,

Sorry just what I'd noticed... V unusual.

Rob and the Offer's been 200K+ on Auto most of the morning.

Cleaner

And?

WTP

Absolutely not.

If I thought that the CEO had done this to the SP I'd be incredulous and calling for a vote of confidence at an EGM

I suppose the idea of holding steady while the CEO trashes the SP is reasonable (in some people's book).

As far as I'm concerned it's a sacking offence! If sacked at least the alleged perpetrator can fall back on the other job.

The hoped for RNS is now a disclosure of options exercise with selling to fund it?

Heavens above... what a shambles.

Maybe it's a "clever" way of managing someone's personal tax?

Better not be!

So if it isn't the alleged actions re options why?

I wonder......

AIMO

Well according to some our CEO is causing the problem.

I darned well hope not!!!!

If Prof Durrant is dumping shares on the market not only would I suggest it's despicable but what message does it send to investors if instead of holding for the big payout she's running for cover?

Maybe she's more astute an investor than a CEO?

I don't actually agree with your view about options but if that was the case then there's some questions to be answered at the AGM unless someone fancies calling for an EGM in those circumstances.

AIMO

WTP

The only way to find out is to keep buying (If you think it's deliberate on the downside.

Actually why do you think it's a deliberate move and more importantly, by whom? I hope you're not implicating the BOD in your conjecture.

Does anyone here really think that a Nasdaq listing is a good idea?

TBH that worries me more than somewhat..

I wonder whether the company will have the same shareholders (or BOD) as it does now?

At least we know that there'll be a great deal many more of them (Shareholders that is).

Bit of a double edged sword IMO.

@DeAar

"Mountain out of a molehill me thinks. Try see the glass half full sometimes."

How's this from my post here this morning,

"...Fingers crossed that Scancell are beginning to grow in a good and controlled direction.

The future's looking brighter."

That glass half full enough for you? It's not my fault that communications from this morning were not assisted by comments this afternoon.

@WTP

I "HOPE" that Scancell's IP is managed as effectively and as professionally as possible. Considering we have what many here have called world beating platforms isn't it rather sad that instead of nurturing the assets we're seeing what looks like the future as a full blown stage three trial company requiring massive resources when perhaps it might be better to let others who have the facilities capital and expertise bring the shareholders' valuable treasure to the market. So far we've seen this company achieve a great deal to get to where we are now.... BUT those assets need to be moved forward as quickly as possible, not being kept in what we now know to be an under resourced company which cannot rely on organic funding of future trials from within. The market for Capital seems unlikely to ease to any great extent any time soon, and boy, if Scancell reckon on taking Platforms through stage three trials on their own I'm concerned for the BOD's ability to manage that journey (based on history).

Since many here are saying that the IP we own for Cancer sufferers now and in the future is the best, maybe that IP should be serviced by Organisations which have the wherewithal and experience to get things done. I personally don't think Scancell have that ability as presently constructed (or even after September (or whenever the new guy turns up.).

So in answer to your loaded question, see my 9.04 post this morning and why I'm so annoyed now with the "Funding" comments, No I don't HOPE that SCLP stock goes down in value. I think it would be useful if maybe we let a company that has the proven ability take it forward.

Why would I say this?

Because I have shares in Scancell and I don't want to see their value eroded by inexperience and conflicting interests.

Commercialisation is the watchword now, and that seemed to be evident from the RNS (which I agreed with) this morning. The slant has now changed a little, so that's why I'm not as optimistic tonight as I was earlier.

AIMO

Chippy Jo

It doesn't give much faith when the BB's been talking about funding the future with milestones and sales of assets but later that same day the CEO says we may have to raise funds.

Briliiant, if the company's runway might now be shorter than it was first thing today.

No, sorry, another Scancell attempt to put a hole in of one of its feet IMO

AIMO

From the RNS first thing this morning:

"Due to the company increasing focus on its two clinical assets, Scancell is fully funded to 2H 2024 including the near-term data inflection points and near-term cohort expansions outlined above."

= Good news.

Later in the day,

"She (LD) adds that the company is "well financed" with a runway extending into the second half of 2024, but makes it clear that the continued emergence of promising clinical data could make a fundraise necessary - saying that "clearly a company of our size always needs to think about that as we go forward.""

Brilliant!

Why say it, it's obvious; but no, we'll make sure the (Guarded) enthusiasm for a well focused controlled Company plan is blown apart with the sort of comments that don't engender a positive view of the future being funded by adroit sales of assets as they're proven.

Sorry, but that's my slant on the matter.

Others will disagree, that's what a market's all about.

We can see what happens.

AIMO

WTP

Because we know that it's a waiting game and now there's doubt about Finance again after it was shut down first thing this morning.

Reckon that RM's about to put off their Capital coming back in 25? Doesn't look like the BOD are that convinced does it?

Again, AIMO

OK, so you come out with an RNS that basically says all's well on the finance front until 2nd half 24, now she's managed to bring the subject to the fore within hours of the release.

That's being a good CEO for her shareholderrs?

Not in my book it isn't!

So much for focused Commercials...

Oh well, lets see what the SP makes of that little gem!

AIMO

Talk about snatching defeat from the jaws of Victory.......

"She adds that the company is "well financed" with a runway extending into the second half of 2024, but makes it clear that the continued emergence of promising clinical data could make a fundraise necessary - saying that "clearly a company of our size always needs to think about that as we go forward."

AIMO

Well, at Least Diggle's frustration has been addressed.

Now Scancell must keep to their advertised timelines re Top Line results.

As a couple of posters have already suggested the output seems much more professional.

Fingers crossed that Scancell are beginning to grow in a good and controlled direction.

The future's looking brighter.

AIMO